Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

BA.5 transmissibility, new mask mandates, and the WHO declaration regarding monkeypox

By Yvonne Puig (US) & Daphne Calderon (US) on July 25, 2022
Email this postTweet this postLike this postShare this post on LinkedIn
physicianlab

Between 60 to 75 percent of new COVID-19 diagnoses are now said to be attributed the BA.5 variant.  Health officials have advised anyone who has not had a second booster to do so now, with fears that existing immunity could be waning.  Researchers have branded BA.5 the worst variation yet, one that has increased the risk of reinfection, and in some reported cases, as early as four weeks after having COVID.  Several cities and counties are considering a return to indoor mask mandates as cases continue to rise.  Los Angeles County has announced it is planning to reinstate its indoor mask mandate on July 29, 2022.

The World Health Organization (WHO) declared the monkeypox outbreak a public health emergency of international concern.  The US is reporting close to 3,000 probable or confirmed monkeypox cases in 44 states, DC and Puerto Rico.  The monkeypox virus can spread through contact with body fluids, sores, clothing, or bedding containing the virus.  According to the CDC, it can also spread through respiratory droplets, with persons in close settings.

Norton Rose Fulbright lawyers will continue to provide relevant updates for healthcare providers on the Health Law Pulse regarding public health crisis.

Photo of Yvonne Puig (US) Yvonne Puig (US)

US Head of Life Sciences and Healthcare Yvonne Puig has a substantial commercial litigation practice in both state and federal courts. She represents hospitals, HMOs, managed care organizations, medical schools and other institutional health care providers and educational services companies. A partner in…

US Head of Life Sciences and Healthcare Yvonne Puig has a substantial commercial litigation practice in both state and federal courts. She represents hospitals, HMOs, managed care organizations, medical schools and other institutional health care providers and educational services companies. A partner in Norton Rose Fulbright’s Austin office, Yvonne’s practice involves commercial and health care litigation, antitrust, regulatory and compliance advice, crisis management, staff privileges, exclusive contracting and administrative law.

Read more about Yvonne Puig (US)Email
Show more Show less
Photo of Daphne Calderon (US) Daphne Calderon (US)
Read more about Daphne Calderon (US)Email
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Health Law Pulse
  • Organization:
    Norton Rose Fulbright
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo